The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel
Abstract
Introduction Chronic hepatitis C (HCV) infection is currently one of the most clinically relevant comorbidities in the HIV population; overall, it affects one third of HIV-positive individuals [1]. Progression to end-stage liver disease occurs faster in coinfected patients [2–4] and decompensated cirrhosis is one of the main causes of hospitalization and death in this population [5–8]. However, the risk of hepatotoxicity using antiretroviral drugs is increased in subjects with underlying HCV infection [9,10]. Therefore, the optimal management of chronic HCV in HIV-positive patients is currently a priority. Several guidelines for caring for HCV infection in HIV-positive individuals have been released [11–15]. Because new and relevant information has recently appeared, it is convenient to update them. Eleven areas have been identified in which new recommendations are particularly needed: management of patients with persistently normal aminotransferases liver fibrosis assessment: when and how predictors of response to anti-HCV therapy in coinfected patients optimal dosages of pegylated interferon (pegIFN) and ribavirin (RBV) optimal duration of anti-HCV therapy treatment of non-responders and/or relapsers care of patients with end-stage liver disease treatment of acute HCV infection in HIV-infected individuals management of patients with multiple hepatitis viruses interactions between HCV medications and antiretroviral drugs hepatotoxicity of antiretroviral drugs. Patients with persistently normal aminotransferases The exact definition of persistently normal aminotransferases is not well established in patients with chronic HCV infection. Fluctuations in aspartate/alanine aminotransferases (AST/ALT) are frequent in HCV-related liver disease and differences in the prevalence of persistently normal ALT may reflect the length of follow-up and/or the number of biochemical determinations made [16–18]. We propose a definition requiring the demonstration of normal ALT in at least three consecutive tests made at least 2 months apart each, over a period of 12 months. One third of individuals who initially meet these criteria, however, may show ALT elevations as the period of observation extends [19–22]. Therefore, the characterization of patients with normal ALT should not be based on sporadic determinations of liver enzymes, and the term ‘asymptomatic’ or ‘healthy’ HCV carrier is inappropriate [22]. A further consideration is that the so-called ‘normal’ limit of aminotransferases has to be revisited, since recent studies have shown that aminotransferase levels in subjects without any liver injury [23] or in persons free of liver-related death on follow-up [24] are definitely lower than those accepted as normal in the past. The degree of aminotransferase elevation generally reflects the extent of liver inflammation. Around 25% of HCV-monoinfected patients show persistently normal ALT [19–22,25] and liver disease is generally less severe in this group [25–28]. Women tend to show more frequently persistently normal ALT than men [28], as well as subjects infected with HCV genotype 4 [29–31]. In contrast, patients with HCV genotype 3 show normal ALT less frequently [31]. As expected considering the immune-mediated nature of HCV-related liver disease, there is little correlation between serum HCV RNA and aminotransferases [32]. Few studies have been conducted so far in coinfected patients with normal ALT. Only 7–9% of this population show persistently normal liver enzymes [31,33]. Exposure to antiretroviral drugs, alcohol abuse and other conditions explain, on the one hand, the lower rate of normal ALT in HIV-positive patients with chronic HCV infection. On the other hand, significant liver fibrosis has been reported in up to 25–40% of coinfected patients with normal ALT [31,33], a prevalence higher than the 10–30% reported in HCV-monoinfected individuals [28,34]. In two recent studies, 12–14% of coinfected patients with normal ALT had cirrhosis on liver biopsy [33,35]. Since less than 15% of HCV-monoinfected individuals with minimal or absent liver fibrosis progress to cirrhosis within 15 years [36], and most patients with normal ALT have mild liver disease [37], these individuals have formerly not been considered for HCV therapy. Moreover, flares in ALT activity and lower treatment responses were reported in the past in patients with normal ALT exposed to IFN, which further discouraged their treatment. However, recent studies in HCV-monoinfected patients have alerted clinicians to the higher liver fibrosis progression in initially mild chronic HCV infection [38] and similar responses to pegIFN plus ribavirin RBV have been obtained in patients with normal than with elevated aminotransferases [39]. Recommendation Given that the prevalence of and progression to advanced liver fibrosis in patients with normal ALT is higher in HIV-positive patients [31,33], these patients should be considered for anti-HCV therapy. Treatment sh
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bedossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,376
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04396-4 · Cited by 2,093
Ziol, M., Handra-Luca, A., Kettaneh, A., Christidis, C., Mal, F., Kazemi, F., de Lédinghen, V., Marcellin, P., Dhumeaux, D., Trinchet, J.-C., et al. (2005) · Hepatology · doi:10.1002/hep.20506 · Cited by 1,470
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445 · cited 1×
“without any liver injury [23] or in persons free of liver-related death on follow-up [24] are definitely lower than those accepted as normal in the past.”
BackgroundDiagnosis of cirrhosis by transient elastography (FibroScan): a prospective study
Foucher, J. (2006) · Gut · doi:10.1136/gut.2005.069153 · Cited by 1,284
Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-García, J., Lazzarin, A., Carosi, G., Sasadeusz, J., Katlama, C., Montaner, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040842 · Cited by 1,233
Self-citationLiver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
Self-citationIdentification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
Forns, X. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00107-6 · Cited by 1,125
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Epidemiology of viral hepatitis and HIV co-infection
Alter, M. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.004 · Cited by 1,012
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
Cadranel, J.-F., Rufat, P., & Degos, F. (2000) · Hepatology · doi:10.1053/jhep.2000.16602 · Cited by 993
Bica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., & Snydman, D. R. (2001) · Clinical Infectious Diseases · doi:10.1086/318501 · Cited by 974
McHutchison, J. G., Manns, M., Patel, K., Poynard, T., Lindsay, K. L., Trepo, C., Dienstag, J., Lee, W. M., Mak, C., Garaud, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35950 · Cited by 969
Sulkowski, M. S. (2000) · JAMA · doi:10.1001/jama.283.1.74 · Cited by 950
Self-citationChung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032653 · Cited by 875
Self-citationMicallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, A., Santoro, R., Minerva, N., Ricci, G. L., Carretta, V., Persico, M., Vinelli, F., Scotto, G., Bacca, D., Annese, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042608 · Cited by 840
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 816
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
van Leth, F., Phanuphak, P., Ruxrungtham, K., Baraldi, E., Miller, S., Gazzard, B., Cahn, P., Lalloo, U., van der Westhuizen, I., Malan, D., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15997-7 · Cited by 684
Hyeon, C. K., Chung, M. N., Sun, H. J., Kwang, H. H., Kyu Oh, D., & Suh, I. (2004) · BMJ · doi:10.1136/bmj.38050.593634.63 · Cited by 600
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Marcellin, P., Ziol, M., Bedossa, P., Douvin, C., Poupon, R., De Lédinghen, V., & Beaugrand, M. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01802.x · Cited by 535
Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., & Spengler, U. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14844-1 · Cited by 525
Self-citationGerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Sulkowski, M. S., Thomas, D. L., Mehta, S. H., Chaisson, R. E., & Moore, R. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30319 · Cited by 523
Self-citationShiffman, M. L., Di Bisceglie, A. M., Lindsay, K. L., Morishima, C., Wright, E. C., Everson, G. T., Lok, A. S., Morgan, T. R., Bonkovsky, H. L., & Lee, W. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.014 · Cited by 453
Hepatitis C and Progression of HIV Disease
Sulkowski, M. S. (2002) · JAMA · doi:10.1001/jama.288.2.199 · Cited by 445
Self-citationSoriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Cargnel, A., Mauss, S., Dieterich, D., Moreno, S., et al. (2002) · AIDS · doi:10.1097/00002030-200204120-00001 · Cited by 444
Self-citation46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Vila, J., & Bonomo, R. A. (2007) · Future Microbiology · doi:10.2217/17460913.2.1.9 · Cited by 420
den Brinker, M., Wit, F. W. N. M., Wertheim-van Dillen, P. M. E., Jurriaans, S., Weel, J., van Leeuwen, R., Pakker, N. G., Reiss, P., Danner, S. A., Jan Weverling, G., et al. (2000) · AIDS · doi:10.1097/00002030-200012220-00011 · Cited by 390
Laguno, M., Murillas, J., Blanco, J. L., Martínez, E., Miquel, R., Sánchez-Tapias, J. M., Bargallo, X., García-Criado, A., Lazzari, E. D., Larrousse, M., et al. (2004) · AIDS · doi:10.1097/00002030-200409030-00003 · Cited by 387
Rockstroh, J. K., Mocroft, A., Soriano, V., Tural, C., Losso, M. H., Horban, A., Kirk, O., Phillips, A., Ledergerber, B., Lundgren, J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/432762 · Cited by 383
Self-citationAlberti, A., Clumeck, N., Collins, S., Gerlich, W., Lundgren, J., Palù, G., Reiss, P., Thiebaut, R., Weiland, O., Yazdanpanah, Y., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.003 · Cited by 382
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
Dixit, N. M., Layden-Almer, J. E., Layden, T. J., & Perelson, A. S. (2004) · Nature · doi:10.1038/nature03153 · Cited by 369
Bräu, N., Salvatore, M., Ríos-Bedoya, C. F., Fernández-Carbia, A., Paronetto, F., Rodríguez-Orengo, J. F., & Rodríguez-Torres, M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.006 · Cited by 359
Self-citationde Lédinghen, V., Douvin, C., Kettaneh, A., Ziol, M., Roulot, D., Marcellin, P., Dhumeaux, D., & Beaugrand, M. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000194238.15831.c7 · Cited by 354
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
Martínez, E., Blanco, J. L., Arnaiz, J. A., Pérez-Cuevas, J. B., Mocroft, A., Cruceta, A., Marcos, M. A., Milinkovic, A., García-Viejo, M. A., Mallolas, J., et al. (2001) · AIDS · doi:10.1097/00002030-200107060-00007 · Cited by 349
Eron, J., Yeni, P., Gathe, J., Estrada, V., DeJesus, E., Staszewski, S., Lackey, P., Katlama, C., Young, B., Yau, L., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69155-1 · Cited by 344
Patel, K., Gordon, S. C., Jacobson, I., Hézode, C., Oh, E., Smith, K. M., Pawlotsky, J.-M., & McHutchison, J. G. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.008 · Cited by 330
Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
Lafeuillade, A., Hittinger, G., & Chadapaud, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03618-7 · Cited by 319
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
Núñez, M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.027 · Cited by 313
Mathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270333 · Cited by 302
Martin‐Carbonero, L., Benhamou, Y., Puoti, M., Berenguer, J., Mallolas, J., Quereda, C., Arizcorreta, A., Gonzalez, A., Rockstroh, J., Asensi, V., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380130 · Cited by 272
Self-citationSurvival in patients with HIV infection and viral hepatitis B or C: a cohort study
Bonacini, M., Louie, S., Bzowej, N., & Wohl, A. R. (2004) · AIDS · doi:10.1097/00002030-200410210-00008 · Cited by 264
Rosenthal, E., Poirée, M., Pradier, C., Perronne, C., Salmon-Ceron, D., Geffray, L., Myers, R. P., Morlat, P., Pialoux, G., Pol, S., et al. (2003) · AIDS · doi:10.1097/00002030-200308150-00009 · Cited by 262
Self-citationChariot, P., Drogou, I., Lacroix-Szmania, I. D., Eliezer-Vanerot, M.-C., Chazaud, B., Lombès, A., Schaeffer, A., & Zafrani, E. S. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80020-8 · Cited by 260
Shakil, A. O., Conry-Cantilena, C., Alter, H. J., Hayashi, P., Kleiner, D. E., Tedeschi, V., Krawczynski, K., Conjeevaram, H. S., Sallie, R., Bisceglie, A. M. D., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-5-199509010-00002 · Cited by 254
Shiffman, M. L., Hofmann, C. M., Contos, M. J., Luketic, V. A., Sanyal, A. J., Sterling, R. K., Ferreira-Gonzalez, A., Mills, A. S., & Garret, C. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70402-6 · Cited by 254
Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 252
Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral Therapy
Núñez, M., Lana, R., Mendoza, J. L., Martín-Carbonero, L., & Soriano, V. (2001) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200108150-00002 · Cited by 251
Self-citationPuoti, M., Bruno, R., Soriano, V., Donato, F., Gaeta, G. B., Quinzan, G. P., Precone, D., Gelatti, U., Asensi, V., & Vaccher, E. (2004) · AIDS · doi:10.1097/00002030-200411190-00009 · Cited by 249
Self-citationZeuzem, S., Diago, M., Gane, E., Reddy, K. R., Pockros, P., Prati, D., Shiffman, M., Farci, P., Gitlin, N., O’Brien, C. B., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.050 · Cited by 246
Martinez‐Sierra, C., Arizcorreta, A., Diaz, F., Roldan, R., Martin‐Herrera, L., Perez‐Guzman, E., & Giron‐Gonzalez, J. A. (2003) · Clinical Infectious Diseases · doi:10.1086/367643 · Cited by 244
Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects
Sanne, I., Mommeja‐Marin, H., Hinkle, J., Bartlett, J. A., Lederman, M. M., Maartens, G., Wakeford, C., Shaw, A., Quinn, J., Gish, R. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428093 · Cited by 242
Performance of serum marker panels for liver fibrosis in chronic hepatitis C
Parkes, J., Guha, I. N., Roderick, P., & Rosenberg, W. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.019 · Cited by 239
Cammà, C., Di Bona, D., Schepis, F., Heathcote, J. E., Zeuzem, S., Pockros, P. J., Marcellin, P., Balart, L., Alberti, A., & Craxì, A. (2004) · Hepatology · doi:10.1002/hep.20073 · Cited by 227
Kelleher, T. B., Mehta, S. H., Bhaskar, R., Sulkowski, M., Astemborski, J., Thomas, D. L., Moore, R. E., & Afdhal, N. H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.025 · Cited by 227
Self-citationSurvival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients
Ragni, M. V., Belle, S. H., Im, K., Neff, G., Roland, M., Stock, P., Heaton, N., Humar, A., & Fung, J. F. (2003) · The Journal of Infectious Diseases · doi:10.1086/379254 · Cited by 223
Care of patients with hepatitis C and HIV co-infection
Soriano, V., Puoti, M., Sulkowski, M., Mauss, S., Cacoub, P., Cargnel, A., Dieterich, D., Hatzakis, A., & Rockstroh, J. (2004) · AIDS · doi:10.1097/00002030-200401020-00001 · Cited by 222
Self-citationMartín-Carbonero, L., Soriano, V., Valencia, E., García-Samaniego, J., López, M., & González-Lahoz, J. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220152644160 · Cited by 221
Self-citationDisorders of Glucose Metabolism in Patients Infected with Human Immunodeficiency Virus
Dubé, M. P. (2000) · Clinical Infectious Diseases · doi:10.1086/317491 · Cited by 218
Lindahl, K., Ståhle, L., Bruchfeld, A. N., & Schvarcz, R. (2005) · Hepatology · doi:10.1002/hep.20563 · Cited by 215
Kamal, S. M., Fouly, A. E., Kamel, R. R., Hockenjos, B., Al Tawil, A., Khalifa, K. E., He, Q., Koziel, M. J., El Naggar, K. M., Rasenack, J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.034 · Cited by 215
Raimondo, G., Brunetto, M. R., Pontisso, P., Smedile, A., Maina, A. M., Saitta, C., Squadrito, G., & Tono, N. (2006) · Hepatology · doi:10.1002/hep.20944 · Cited by 207
Myers, R. P., Benhamou, Y., Imbert-Bismut, F., Thibault, V., Bochet, M., Charlotte, F., Ratziu, V., Bricaire, F., Katlama, C., & Poynard, T. (2003) · AIDS · doi:10.1097/00002030-200303280-00010 · Cited by 203
Self-citationColletta, C., Smirne, C., Fabris, C., Toniutto, P., Rapetti, R., Minisini, R., & Pirisi, M. (2005) · Hepatology · doi:10.1002/hep.20814 · Cited by 201
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
Pérez-Olmeda, M., Núñez, M., Romero, M., González, J., Castro, A., Arribas, J. R., Pedreira, J., Barreiro, P., García-Samaniego, J., Martín-Carbonero, L., et al. (2003) · AIDS · doi:10.1097/00002030-200305020-00011 · Cited by 200
Self-citationPuoti, M., Bonacini, M., Spinetti, A., Putzolu, V., Govindarajan, S., Zaltron, S., Favret, M., Callea, F., Gargiulo, F., Donato, F., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/317644 · Cited by 195
Self-citationHepatotoxicity after introduction of highly active antiretroviral therapy
Rodríguez-Rosado, R., García-Samaniego, J., & Soriano, V (1998) · AIDS · doi:10.1097/00002030-199810000-00025 · Cited by 190
Self-citationLiver toxicity caused by nevirapine
González de Requena, D., Núñez, M., Jiménez-Nácher, I., & Soriano, V. (2002) · AIDS · doi:10.1097/00002030-200201250-00020 · Cited by 176
Self-citation(2015) · Diagnostic Pathology: Infectious Diseases · doi:10.1016/b978-0-323-37677-8.50024-3 · Cited by 172
Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection
Alberti, A., Noventa, F., Benvegnù, L., Boccato, S., & Gatta, A. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00009 · Cited by 167
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs
Maida, I., Núñez, M., Ríos, M. J., Martín-Carbonero, L., Sotgiu, G., Toro, C., Rivas, P., Barreiro, P., Mura, M. S., Babudieri, S., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000221683.44940.62 · Cited by 167
Self-citationSulkowski, M. S., Mehta, S. H., Chaisson, R. E., Thomas, D. L., & Moore, R. D. (2004) · AIDS · doi:10.1097/00002030-200411190-00008 · Cited by 162
Self-citationAceti, A., Pasquazzi, C., Zechini, B., & Bac, C. D. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200201010-00005 · Cited by 160
Wong, J. B., & Koff, R. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00008 · Cited by 155
Aranzabal, L., Casado, J. L., Moya, J. L., Quereda, C., Diz, S. D. L., Moreno, A., Moreno, L., Antela, A., Pérez-Elías, M. J., Dronda, F., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427216 · Cited by 148
Anderson, K. B., Guest, J. L., & Rimland, D. (2004) · Clinical Infectious Diseases · doi:10.1086/425360 · Cited by 144
Prati, D., Capelli, C., Zanella, A., Mozzi, F., Bosoni, P., PAPPALETTERA, M., Zanuso, F., Vianello, L., Locatelli, E., Fazio, C., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536854 · Cited by 131
Gilleece, Y. C., Browne, R., Asboe, D., Atkins, M., Mandalia, S., Bower, M., Gazzard, B., & Nelson, M. R. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000174930.64145.a9 · Cited by 130
Clinical Presentation and Course of Acute Hepatitis C Infection in HIV-Infected Patients
Luetkemeyer, A. F., Hare, C. B., Stansell, J., Tien, P. C., Charlesbois, E., Lum, P. J., Havlir, D. V., & Peters, M. G. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000191281.77954.27 · Cited by 129
Self-citationIncidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine
Martín‐Carbonero, L., Marina, N., Juan, G.-L., & Soriano, V. (2003) · HIV Clinical Trials · doi:10.1310/n4vt-3e9u-4bkn-crpw · Cited by 124
Self-citationMacı́as, J., González, J. A. G., González-Serrano, M., Merino, D., Cano, P., Mira, J. A., Arizcorreta-Yarza, A., Ruíz-Morales, J., Lomas-Cabeza, J. M., García-García, J. Á., et al. (2005) · Gut · doi:10.1136/gut.2005.065904 · Cited by 123
Liu, C., Chen, P., Lai, M.-Y., Kao, J., Jeng, Y., & Chen, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50096 · Cited by 122
Acute hepatitis C in HIV-infected men who have sex with men.
Ghosn, J., Pierre‐François, S., Thibault, V, Duvivier, C., Tubiana, R., Simon, A., Valantin, M., Dominguez, S., Caumes, E., & Katlama, C. (2004) · HIV Medicine · doi:10.1111/j.1468-1293.2004.00225.x · Cited by 111
Moreno, L., Quereda, C., Moreno, A. M., Pérez-Elı́as, M. J., Antela, A., Casado, J. L., Dronda, F., Mateos, M. L., Bárcena, R., & Moreno, S. (2004) · AIDS · doi:10.1097/00002030-200401020-00008 · Cited by 107
Hepatotoxicity of Antiretrovirals
ez, M. N., & Soriano, V. (2005) · Drug Safety · doi:10.2165/00002018-200528010-00004 · Cited by 106
Self-citationDominguez, S., Ghosn, J., Valantin, M., Schruniger, A., Simon, A., Bonnard, P., Caumes, É., Pialoux, G., Benhamou, Y., Thibault, V., et al. (2006) · AIDS · doi:10.1097/01.aids.0000226956.02719.fd · Cited by 106
Self-citationTorriani, F. J., Ribeiro, R. M., Gilbert, T., Schrenk, U. M., Clauson, M., Pacheco, D. M., & Perelson, A. S. (2003) · The Journal of Infectious Diseases · doi:10.1086/379255 · Cited by 101
Shindo, M. (1995) · Hepatology · doi:10.1016/0270-9139(95)90560-x · Cited by 100
Lenzo, N. P., Garas, B. A., & French, M. A. (1997) · AIDS · doi:10.1097/00002030-199710001-00003 · Cited by 99
Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients
Sherman, K. E., Shire, N. J., Rouster, S. D., Peters, M. G., Koziel, M. J., Chung, R. T., & Horn, P. S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.059 · Cited by 99
Self-citationEfficacy of non-invasive elastometry on staging of hepatic fibrosis
Saito, H. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.03.007 · Cited by 93
Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort
Gebo, K. A., Diener‐West, M., & Moore, R. D. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200310010-00006 · Cited by 92
Okanoue, T., Makiyama, A., Nakayama, M., Sumida, Y., Mitsuyoshi, H., Nakajima, T., Yasui, K., Minami, M., & Itoh, Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.008 · Cited by 77
Fibrosis progression in initially mild chronic hepatitis C
Boccato, S., Pistis, R., Noventa, F., Guido, M., Benvegnù, L., & Alberti, A. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00683.x · Cited by 73
Bräu, N., Rodriguez‐Torres, M., Prokupek, D., Bonacini, M., Giffen, C. A., Smith, J. J., Frost, K. R., & Kostman, J. R. (2004) · Hepatology · doi:10.1002/hep.20107 · Cited by 71
Self-citationVogel, M., Bieniek, B., Jessen, H. K., Schewe, C., Hoffmann, C., Baumgarten, A., Kroidl, A., Bogner, J. R., Spengler, U., & Rockstroh, J. K. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00580.x · Cited by 64
Self-citationBarreiro, P., Martín‐Carbonero, L., Nunez, M., Rivas, P., Morente, A., Simarro, N., Labarga, P., González‐Lahoz, J., & Soriano, V. (2006) · Clinical Infectious Diseases · doi:10.1086/501021 · Cited by 61
Self-citationThe Clinical Spectrum of Hepatitis C Virus in HIV Coinfection
Sterling, R. K., Contos, M. J., Sanyal, A. J., Luketic, V. A., Stravitz, R. T., Wilson, M. S., Mills, A. S., & Shiffman, M. L. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200301010-00005 · Cited by 52
Myers, R. P., Benhamou, Y., Bochet, M., Thibault, V., Mehri, D., & Poynard, T. (2004) · AIDS · doi:10.1097/00002030-200401020-00009 · Cited by 51
Self-citationAlberti, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.004 · Cited by 49
Nelson, M. R., Matthews, G. V., Brook, M. G., & Main, J. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00300.x · Cited by 49
Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched
Pinzani, M. (2006) · Gut · doi:10.1136/gut.2005.068585 · Cited by 48
Sim, S. M., Hoggard, P. G., Sales, S. D., Phiboonbanakit, D., Hart, C. A., & Back, D. J. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.1661 · Cited by 46
Landau, A., Batisse, D., Piketty, C., Jian, R., & Kazatchkine, M. D. (2000) · AIDS · doi:10.1097/00002030-200008180-00025 · Cited by 46
HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy
Puoti, C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00018-7 · Cited by 44
Laguno, M., Blanch, J., Murillas, J., Blanco, J. L., León, A., Loncà, M., Larrousse, M., Biglia, A., Martínez, E., García, F., et al. (2004) · Antiviral Therapy · doi:10.1177/135965350400900604 · Cited by 41
Vogel, M., Voigt, E., Schäfer, N., Goldmann, G., Schwarz, N. T., Kalff, J. C., Sauerbruch, T., Wolff, M. J., Rockstroh, J. K., & Spengler, U. (2005) · Liver Transplantation · doi:10.1002/lt.20498 · Cited by 41
Self-citationDisseminated cysticercosis involving orbit, brain and subcutaneous tissue
Pushker, N., Bajaj, M., & Balasubramanya, R. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.04.011 · Cited by 39
Hopkins, S., Lambourne, J., Farrell, G., McCullagh, L., Hennessy, M., Clarke, S. J., Mulcahy, F., & Bergin, C. J. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00365.x · Cited by 26
Liver steatosis in HIV-infected patients.
Piroth, L. (2005) · PubMed · Cited by 20
Santín, M., Shaw, E., Garcia, M. J., Delejido, A., de Castro, E. R., Rota, R., Altés, J., Baguena, F., Valero, S., Sala, M., et al. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.315 · Cited by 18
Ratziu, V., Charlotte, F., Jacqueminet, S., Giral, P., Podevin, P., Serfaty, L., Bruckert, É., & Poynard, T. (2006) · Journal of Hepatology · doi:10.1016/s0168-8278(06)80738-5 · Cited by 17
Batisse, D., Huyen, J. P. D. V., Piketty, C., Canali, G. G., Karmochkine, M., Weiss, L., Bruneval, P., & Kazatchkine, M. D. (2002) · AIDS · doi:10.1097/00002030-200211220-00033 · Cited by 9
Cited by
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837
Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., Yanny, I., Razavi, H., & Vickerman, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00485-5 · Cited by 731
Viral hepatitis and HIV coinfection
Sulkowski, M. S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.009 · Cited by 316
Self-citationRockstroh, J., Bhagani, S., Benhamou, Y., Bruno, R., Mauss, S., Peters, L., Puoti, M., Soriano, V, Tural, C., & the EACS Executive Committee (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00535.x · Cited by 255
Self-citationvan de Laar, T. J., Matthews, G. V., Prins, M., & Danta, M. (2010) · AIDS · doi:10.1097/qad.0b013e32833c11a5 · Cited by 252
Metadata
- Authors
- Soriano, V., Puoti, M., Sulkowski, M., Cargnel, A., Benhamou, Y., Peters, M., Mauss, S., Bräu, N., Hatzakis, A., Pol, S., & Rockstroh, J.
- Venue
- AIDS
- Published
- 2007-05-31
- Volume
- 21
- Issue
- 9
- Pages
- 1073-1089
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2097073538
- Cited by
- 349
- References
- 123
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.